Trial conversion is where a lot of otherwise healthy SaaS businesses quietly lose most of their revenue. People sign up, poke around, and then the trial expires and nothing happens. No cancellation, no complaint, no conversation — just a card that never gets entered.
The instinct is to treat this as a sales problem and add more emails, more discounts, more urgency. Usually it is a design problem. A trial is not a free sample; it is a structured argument that your product is worth paying for, and most trials never make the argument at all.
Decide What the Trial Is Proving
Before touching the mechanics, answer one question: what specifically does a user need to experience to conclude that this is worth paying for?
Not "understand the features." Not "explore the interface." A single concrete outcome. They imported their data and saw the report they could never build before. They ran a campaign and got replies. They invited a colleague and the two of them finished something together.
Everything about the trial should be engineered to deliver that experience, and anything that does not contribute to it is a distraction. Most trials fail because they were designed to showcase the product rather than to produce an outcome.
Once you can name the outcome, you have a definition of success that is measurable, and a clear brief for onboarding, emails, and in-app guidance.
Time-Limited or Usage-Limited?
The default fourteen-day trial is a convention, not a conclusion. Two structures dominate, and they suit different products.
Time-limited trials create natural urgency and a clean deadline. They work when your product delivers value quickly and continuously — a user can meaningfully evaluate it within days. Their weakness is that the clock runs regardless of engagement. Someone who signs up on a Friday, gets pulled into a launch week, and returns on day twelve has effectively had a two-day trial.
Usage-limited trials grant a quantity — a number of reports, records, sends, or seats — and let the user consume it at their own pace. These suit products where value arrives in discrete events rather than continuously, and they align the trial with actual engagement rather than the calendar. Their weakness is weaker urgency: with no deadline, there is no moment that forces a decision.
A hybrid often works best: a generous usage allowance with an outer time bound. And whatever you choose, be willing to extend for anyone who asks and is clearly engaged. A user who requests more time is telling you they are interested; refusing on principle to protect a policy is trading revenue for tidiness.
Should You Ask for a Card?
This is the most argued-over trial decision, and the honest answer is that it is a trade, not a best practice.
Requiring a card up front dramatically reduces signups and dramatically increases the conversion rate of those who do sign up, because the people who complete it have already made a purchase decision in principle. You get fewer, better-qualified trials and a smaller support burden.
Not requiring a card maximises top-of-funnel volume, giving you more people to learn from and a larger pool of potential advocates. It also means most trialists were never serious, which makes your conversion metrics look worse and your support queue longer.
For most early-stage products still learning who their customer is, the no-card trial is the better choice, because volume of learning matters more than efficiency of conversion. Once you know your segment well and your onboarding reliably delivers the outcome, requiring a card starts to make sense.
If you do require a card, be conspicuously honest about it: state clearly when the charge happens, email before it does, and make cancellation trivial. Trials that convert through inattention produce refunds, chargebacks, and reviews you do not want.
The First Session Decides Most of It
Trial conversion is largely determined in the first ten minutes, long before any expiry email is sent.
The user arrives with a small budget of patience and a specific hope. If the product delivers something recognisably valuable inside that window, the rest of the trial is confirmation. If it does not, the remaining thirteen days are mostly theatre.
This means the highest-leverage work is compressing the distance to first value. Pre-fill what you can. Offer templates and sample data so an empty account is never the first impression. Defer every configuration decision that is not required for the first outcome. If integration setup is the wall most people hit, make a manual import path available so the wall is optional.
A useful exercise: write down every step between signup and the outcome you defined earlier, then try to halve the list. Most products can, and the ones that do see conversion move more than any email sequence achieves.
Email the Behaviour, Not the Calendar
The standard trial drip — welcome, day three tips, day seven check-in, day twelve warning — is sent on a schedule that ignores what the user has actually done. It nags activated users about basics and offers generic advice to stuck ones.
Trigger on behaviour instead. If someone has not reached the key outcome after two days, send help with the specific step they stalled on. If they reached it, send something that broadens usage — a second use case, a team feature, a workflow they have not tried. If they invited a colleague, treat that as a buying signal and follow up personally.
The expiry sequence deserves particular care. One reminder several days out, one on the final day, and one after expiry offering an easy restart. Frame them around what the user will lose access to — the data they imported, the reports they built, the work they did — rather than around your billing calendar. Loss of one's own work is a far stronger motivator than a discount.
Talk to the Engaged Ones
Somewhere in your trial list is a small group who used the product heavily and still did not convert. These are the most informative people in your business, and almost nobody contacts them.
Email them personally. Not an automated sequence — a short note from a real person: "I noticed you used [product] quite a bit last week and then stopped. Was there something missing?" The reply rate is high because the observation is obviously genuine, and the answers are specific: a missing integration, a pricing mismatch, an approval they could not get internally.
Each of those is actionable in a way that aggregate funnel data never is.
Measure the Right Conversion
A single trial-to-paid percentage hides everything useful. Break it down.
What share of signups reach the key outcome? That is your activation rate, and it usually explains most of the conversion number. What share of activated trials convert? If that figure is healthy and overall conversion is poor, your problem is onboarding, not pricing or sales. If activated users also fail to convert, the problem is value or price.
Separating those two numbers tells you which team should be working on the problem, which is why blended conversion is so often unhelpful.
Make Paying the Obvious Next Step
The best trials do not end with a persuasion attempt. They end at a moment where the user has real work living inside the product, a habit forming around it, and a clear sense of what they lose by walking away.
Get someone to that point and the payment page is a formality. Fail to, and no email sequence, discount, or countdown timer will rescue it.
Design the trial backwards from the outcome. Everything else is decoration.